Featured Products

My Quote Request

No products added yet

6505-01-384-1364

20 Products

NDC00338-0553-11

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841364

NSN

6505-01-384-1364

View More Info

NDC00338-0553-11

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841364

NSN

6505-01-384-1364

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION,USP: 50 ML PLASTIC BAG, 80S
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: EACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 80

2B0043

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

View More Info

2B0043

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 100ML PLASTIC BAG 80 PER PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: EACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 80

F93F131

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

View More Info

F93F131

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

MFG

AIR FORCE MEDICAL LOGISTICS OFFICE

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 100ML PLASTIC BAG 80 PER PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: EACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 80

MINI-BAG PLUS

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

View More Info

MINI-BAG PLUS

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 100ML PLASTIC BAG 80 PER PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: EACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 80

NDC00338-0553-18

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

View More Info

NDC00338-0553-18

SODIUM CHLORIDE INJECTION,USP

NSN, MFG P/N

6505013841365

NSN

6505-01-384-1365

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM CHLORIDE INJECTION USP 100ML PLASTIC BAG 80 PER PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: EACH MINI-BAG PLUS IS A VIAFLEX PLASTIC CONTAINER WITH AN INTEGRAL DRUG VIAL ADAPTER; AVOID EXCESSIVE HEAT; STORE AT ROOM TEMPERATURE
TOTAL PRIMARY CONTAINER QUANTITY: 80

NDC00026-0648-20

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843499

NSN

6505-01-384-3499

View More Info

NDC00026-0648-20

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843499

NSN

6505-01-384-3499

MFG

BAYER PHARMACEUTICALS CORPORATION

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN IMMUNE USP 50ML VIAL
SPECIAL FEATURES: 10 PCT IMMUNE GLOBULIN INJECTION IN 0.2 MOLAR GLYCINE; ONE 50 ML VI; KEEP FROM FREEZING; STORE AT 2-8 DEG. C; HUMAN

NDC13533-0645-20

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843499

NSN

6505-01-384-3499

View More Info

NDC13533-0645-20

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843499

NSN

6505-01-384-3499

MFG

TALECRIS BIOTHERAPEUTICS INC.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN IMMUNE USP 50ML VIAL
SPECIAL FEATURES: 10 PCT IMMUNE GLOBULIN INJECTION IN 0.2 MOLAR GLYCINE; ONE 50 ML VI; KEEP FROM FREEZING; STORE AT 2-8 DEG. C; HUMAN

NDC00026-0648-24

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843500

NSN

6505-01-384-3500

View More Info

NDC00026-0648-24

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843500

NSN

6505-01-384-3500

MFG

TALECRIS BIOTHERAPEUTICS INC.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN IMMUNE USP 200ML VIAL
SPECIAL FEATURES: 10 PCT IMMUNE GLOBULIN INJECTION IN 0.2 MOLAR GLYCINE; ONE 200 ML VI; KEEP FROM FREEZING; STORE AT 2-8 DEG. C; HUMAN

NDC13533-0645-71

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843502

NSN

6505-01-384-3502

View More Info

NDC13533-0645-71

GLOBULIN,IMMUNE INTRAVENOUS (HUMAN) INJECTION

NSN, MFG P/N

6505013843502

NSN

6505-01-384-3502

MFG

TALECRIS BIOTHERAPEUTICS INC.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: GLOBULIN IMMUNE USP 100ML VIAL
SPECIAL FEATURES: 10 PCT IMMUNE GLOBULIN INJECTION IN 0.2 MOLAR GLYCINE; ONE 100 ML VI; KEEP FROM FREEZING; STORE AT 2-8 DEG. C; HUMAN

5226

WATER FOR INHALATION,STERILE,USP

NSN, MFG P/N

6505013843544

NSN

6505-01-384-3544

View More Info

5226

WATER FOR INHALATION,STERILE,USP

NSN, MFG P/N

6505013843544

NSN

6505-01-384-3544

MFG

PROFESSIONAL MEDICAL PRODUCTS INC

Description

FEATURES PROVIDED: STERILE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 600.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
SECONDARY CONTAINER TYPE: PACKAGE
TOTAL PRIMARY CONTAINER QUANTITY: 12

NDC00026-0670-20

ANTIHEMOPHILIC FACT

NSN, MFG P/N

6505013845640

NSN

6505-01-384-5640

View More Info

NDC00026-0670-20

ANTIHEMOPHILIC FACT

NSN, MFG P/N

6505013845640

NSN

6505-01-384-5640

MFG

BAYER PHARMACEUTICALS CORPORATION

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINS 250INTERNATIONAL UNITS ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A 2.5 ML VIAL, WITH ONE VIAL STERILE WATER FOR INJECTION, ONE SPECIAL INFUSION SET, ONE STERILE DOUBLE ENDED TRANSFER NEEDLE; AND ONE STERILE FILTER NEEDLE: NOTE: F,G THPEAKOGENATE BY
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIHEMOPHILIC FACTOR RECOMBINANT 250 I.U. IN A 2.5ML VIAL
~1: MILES PHARM

NDC00026-0670-30

ANTIHEMOPHILIC FACT

NSN, MFG P/N

6505013845746

NSN

6505-01-384-5746

View More Info

NDC00026-0670-30

ANTIHEMOPHILIC FACT

NSN, MFG P/N

6505013845746

NSN

6505-01-384-5746

MFG

BAYER PHARMACEUTICALS CORPORATION

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINS 500 INTERNATIONAL UNITS ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A 5 ML VIAL, WITH ONE VIAL STERILE WATER FOR INJECTION, ONE SPECIAL INFUSION SET, ONE STERILE DOUBLE ENDEDTRANSFER NEEDLE, AND ONE STERILE FILTER NEEDLE: NOTE: F, G;OGEN ATE BY MILES
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIHEMOPHILIC FACTOR RECOMBINANT 500 I.U. IN A 5ML VIAL
~1: PHARM

NDC00185-0704-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

View More Info

NDC00185-0704-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

MFG

EON LABS INC.

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT

NDC00378-0503-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

View More Info

NDC00378-0503-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

MFG

MYLAN PHARMACEUTICALS INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT

NDC00591-0842-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

View More Info

NDC00591-0842-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

MFG

DANBURY PHARMACAL INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT

NDC00781-1824-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

View More Info

NDC00781-1824-01

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

MFG

SANDOZ CONSUMER HEALTH CARE GROUP

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT

NDC51079-0955-20

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

View More Info

NDC51079-0955-20

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

MFG

UDL LABORATORIES INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT

NDC51285-0050-02

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

View More Info

NDC51285-0050-02

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

MFG

DURAMED PHARMACEUTICALS INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT

ZIAC

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

View More Info

ZIAC

BISOPROLOL FUMARATE

NSN, MFG P/N

6505013845864

NSN

6505-01-384-5864

MFG

MYLAN PHARMACEUTICALS INC

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG BISOPROLOL FUMARATE AND 6.25 MG HYDROCHLOROTHIAZIDE; 100 TABLETS PER BOTTLE; THERAPEVTIALLY EQUIVALENT TO ZIAC BY LEDERLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BISOPROLOL FUMATATE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT

NDC00026-0670-50

ANTIHEMOPHILIC FACT

NSN, MFG P/N

6505013845919

NSN

6505-01-384-5919

View More Info

NDC00026-0670-50

ANTIHEMOPHILIC FACT

NSN, MFG P/N

6505013845919

NSN

6505-01-384-5919

MFG

BAYER PHARMACEUTICALS CORPORATION

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: CONTAINS 1,000 INTERNATIONAL UNITS ANTIHEMOPHILIC FACTOR (RECOMBINANT) IN A 10 ML VIAL, WITH ONE VIAL STERILE WATER FOR INJECTION, ONE SPECIAL INFUSION SET, ONE STERILE DOUBLE ENDED TRANSFER NEEDLE, AND ONE STERILE FILTER NEEDLE; NOTE: F, G THPEAKOGENATE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTIHEMOPHILIC FACTOR RECOMBINANT 1000 I.U. IN A 10ML VIAL
~1: BY MILES PHARM